Maynard Um
-
-
-
-
-
-
-
Oppenheimer Downgrades TransMedics Group (TMDX) to Perform
-
-
-
-
-
-
-
TransMedics Group (TMDX) PT Raised to $174 at Needham
-
-
-
-
-
-
-
Piper Sandler on TransMedics Group (TMDX): 'NG Heart Trial Could Deliver Meaningful Upside'
-
-
-
-
-
-
-
Jefferies Starts TransMedics Group (TMDX) at Buy
-
-
-
-
-
-
-
TransMedics Group (TMDX) PT Raised to $142 at Canaccord Genuity
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on TransMedics Group (TMDX)
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Class Action Against TransMedics Group, Inc. (TMDX)
-
418,488 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

